Gefitinib in combination with gemcitabine and carboplatin in never smokers with non-small cell lung carcinoma: a retrospective analysis.

Abstract

INTRODUCTION Randomized placebo-controlled phase III trials failed to show a survival benefit with the addition of gefitinib to platinum-based combination chemotherapy as first-line therapy in unselected patients with advanced non-small cell lung cancer (NSCLC). We conducted a retrospective analysis of the outcome in never smokers with advanced NSCLC who… (More)
DOI: 10.1097/JTO.0b013e3181add9ab

Topics

Cite this paper

@article{Tham2009GefitinibIC, title={Gefitinib in combination with gemcitabine and carboplatin in never smokers with non-small cell lung carcinoma: a retrospective analysis.}, author={Chee Kian Tham and S P Choo and Wan Teck Lim and C S Toh and Swan Swan Leong and Sze-Huey Tan and Hui-hua Li and E. Tan}, journal={Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer}, year={2009}, volume={4 8}, pages={988-93} }